# Milestone Pharmaceuticals
 (stock symbol: MIST) Logo in transparent PNG format

## Milestone Pharmaceuticals
 Logo large

### Milestone Pharmaceuticals
 Logo large Download PNG (54.29 KB)

![Milestone Pharmaceuticals
 Logo large Download PNG (54.29 KB)](/img/orig/MIST_BIG-bae03adf.png)

## Milestone Pharmaceuticals
 Logo icon format

### Milestone Pharmaceuticals
 Logo icon format Download PNG (23.98 KB)

![Milestone Pharmaceuticals
 Logo icon format Download PNG (23.98 KB)](/img/orig/MIST-c41bab66.png)

## About Milestone Pharmaceuticals


Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in MontrÃ©al, Canada.

1. Website domain: milestonepharma.com
2. Employees: 29
3. Marketcap: $0.12 Billion USD


## Categories
- [x] ðŸ‡¨ðŸ‡¦ Canada
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
